Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to -$128.6 million.

  • Prestige Consumer Healthcare's Cash from Investing Activities fell 120969.85% to -$128.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$136.9 million, marking a year-over-year decrease of 37246.44%. This contributed to the annual value of -$17.5 million for FY2025, which is 1322.16% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Cash from Investing Activities of -$128.6 million as of Q4 2025, which was down 120969.85% from -$2.9 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's 5-year Cash from Investing Activities high stood at $2.3 million for Q2 2023, and its period low was -$231.7 million during Q3 2021.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$3.1 million (2022), whereas its average is -$22.2 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first tumbled by 245532.76% in 2021, then surged by 32187.2% in 2023.
  • Over the past 5 years, Prestige Consumer Healthcare's Cash from Investing Activities (Quarter) stood at -$20.2 million in 2021, then skyrocketed by 91.09% to -$1.8 million in 2022, then crashed by 149.36% to -$4.5 million in 2023, then crashed by 118.33% to -$9.8 million in 2024, then crashed by 1209.7% to -$128.6 million in 2025.
  • Its last three reported values are -$128.6 million in Q4 2025, -$2.9 million for Q3 2025, and -$1.9 million during Q2 2025.